TFE3 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions: Moreover, we propose to continuously carry out a prospective cohort study to detailly explore the clinical outcome with the expression of circMET, which helps the development of NONO-TFE3 tRCC diagnosis and treatment.